🔎 Trials Near Me

Domov › Debelost › Texas › Dallas

Klinične študije za Debelost v Dallas, TX

30 študij za Debelost išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Vključevanje udeležencev
  • Baylor Scott & White Institute for Research, Dallas
Starost 18–70 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Vključevanje udeležencevFaza 3
  • UT Southwestern Med Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Vključevanje udeležencevFaza 3
  • North Texas Endocrine Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • UT Southwestern Med Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Vključevanje udeležencevFaza 3
  • Velocity Clinical Res-Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research, Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • UT Southwestern Medical Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • in še 2
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • FutureSearch Trials of Dallas, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Vključevanje udeležencevFaza 3
  • Cedar Health Research, LLC, Dallas
Starost 18–99 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Vključevanje udeležencevFaza 3
  • Cedar Health Research, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Cedar Health Research, LLC, Dallas
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
  • University of Texas Southwestern Medical Center, Dallas
Starost 18–55 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT04838678

Effects of Obesity in the Aged

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Starost 65–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05028309

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2
  • University of Texas, Southwestern, Dallas
Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Vključevanje udeležencevFaza 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Vključevanje udeležencevFaza 3
  • Mercy Family Clinic, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research Dallas, Dallas
Starost 18–80 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07477704

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Vključevanje udeležencev
  • University of Texas Southwestern Medical Center, Dallas
Starost 18–65 · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT06924177

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • UT Southwestern Medical Center, Dallas
Starost 55–90 · Vsi spoli · Posodobljeno 7. maj 2026 · NCT05723679

Leg Heating in Pregnant Women With Obesity

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Starost 18–45 · Ženske · Posodobljeno 17. apr. 2026 · NCT06932250

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Vključevanje udeležencev
  • University of Texas Southwestern, Children's Health, Dallas
Starost 6–14 · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT07342855

Healthy Living BEYOND Weight Study

Vključevanje udeležencevOpazovalna študija
  • American Heart Association, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2025 · NCT07075341

Študije za Debelost v drugih mestih

Druge študije v Dallas

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.